RN7SL28P

Across TCGA pan-cancer cohorts, RN7SL28P RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of RN7SL28P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL28P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL28P is over-expressed in tumor, although a few such as KIRP and LUSC show the opposite, repressed pattern.

COAD, KIRP, and LUSC are the cancer types where RN7SL28P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL28P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	All	+0.683	<.001	8	view →
KIRP	All	All	−0.155	<.001	7	view →
LUSC	Male	II,III,IV	−0.280	<.001	6	view →
BRCA	Female	II,III,IV	+0.176	<.001	6	view →
READ	Female	All	+0.822	.024	2	view →
PAAD	Male	All	+0.385	.019	2	view →
CHOL	Female	All	−0.230	<.001	1	view →
KICH	All	All	−0.115	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

RN7SL28P–COAD

Open the COAD breakdown →